Lewis Nelson, M.D.

Dean and Chief of Health Affairs | Professor of Emergency Medicine / Medical Toxicology Florida Atlantic University

  • Boca Raton FL

Lewis Nelson's research interests span emergency medicine, medical toxicology, and addiction medicine.

Contact

Florida Atlantic University

View more experts managed by Florida Atlantic University

Social

Biography

Lewis S. Nelson, M.D., M.B.A., joins Florida Atlantic University as dean and chief of health affairs at the Charles E. Schmidt College of Medicine. A nationally recognized leader in academic emergency medicine, medical toxicology, and addiction medicine, Dr. Nelson brings over three decades of experience in medical education, clinical care and academic leadership to FAU.

Prior to joining FAU in 2025, Dr. Nelson served as professor and founding chair of Emergency Medicine at Rutgers New Jersey Medical School, where he also held the position of chief of service for the Emergency Department at University Hospital of Newark. His leadership drove remarkable growth: expanding the residency program, doubling the faculty size, establishing five fellowship programs, and increasing clinical revenue while maintaining a strong focus on educational excellence and research productivity. He also served as chief of the Division of Medical Toxicology and Addiction Medicine, developing innovative approaches to the clinical management of poisoning and overdose and addressing complex substance use challenges.

Dr. Nelson has served as president of the Association of Academic Chairs in Emergency Medicine, held positions on the board of directors for the American Board of Emergency Medicine; the Society for Academic Emergency Medicine; and the Accreditation Council for Continuing Medical Education; and led the American College of Medical Toxicology as president. His work with numerous professional organizations and governmental agencies has shaped medical education, health policy, and clinical practice nationally.

Looking forward, Dr. Nelson's vision for the Schmidt College of Medicine focuses on three key areas: expanding research capabilities, advancing clinical excellence through strategic partnerships, and fostering innovation in medical education. This vision, coupled with his commitment to collaborative leadership and community engagement, aligns with FAU's improve health outcomes in South Florida and beyond.

A distinguished scholar, Dr. Nelson has authored over 300 peer-reviewed publications and serves as lead editor of Goldfrank's Toxicologic Emergencies, the definitive text in medical toxicology. His research interests span emergency medicine, medical toxicology, and addiction medicine, with particular focus on opioid use and alcohol withdrawal, patient safety, and public health and health policy challenges.

Areas of Expertise

Emergency Medicine
Medical Toxicology
Addiction Medicine
Medical Education Innovation
Healthcare Quality Improvement
Pharmaceuticals
Health Policy
Opioid Use Disorders
Alcohol Use Disorders
Health Systems Operations

Accomplishments

Outstanding Service Award, American College of Medical Toxicology

2015

Rutgers New Jersey Medical School Faculty Organization, Faculty of the Year

2018

Matthew J. Ellenhorn Career Achievement Award, American College of Medical Toxicology

2018

Show All +

Education

Brandeis University

M.B.A.

State University of New York

M.D.

Emory University

B.S.

Affiliations

  • American College of Emergency Physicians
  • American College of Medical Toxicology
  • American Academy of Clinical Toxicology
  • American Society of Addiction Medicine

Selected Media Appearances

Kambo: The ‘Wellness’ Trend That Makes You Vomit

Medscape  online

2025-09-10

Hi, and welcome. I’m Dr Robert Glatter, medical advisor for Medscape Emergency Medicine. Today, I’ll be speaking with Dr Lewis Nelson, an emergency physician, toxicologist, and dean at the Charles E. Schmidt College of Medicine at Florida Atlantic University, about the adverse effects associated with use of a compound known as kambo. This has recently been gaining popularity as a detox or cleanse among influencers on social media.

View More

South Florida childhood vaccination rates plunge. Who is vulnerable, and why?

Sun Sentinel  online

2025-08-18

Each person’s risk for diseases such as measles varies, said Dr. Lewis Nelson, dean of Florida Atlantic University’s Schmidt College of Medicine.

View More

Plasticizer Spread Rapidly Through Illicit Drug Supply

Medscape  online

2025-07-08

Lewis Nelson, MD, dean of health affairs at Florida Atlantic University in Boca Raton, Florida, and a specialist in emergency medicine and medical toxicology who wasn't involved with the paper, told MedPage Today that BTMPS has been on his radar for about a year and agreed that it appears to be a bulking agent.

View More

Show All +

Selected Articles

Factors Associated with Benzodiazepine Misuse Among Those Who Misused Opioids Within the Past Year: A US National Analysis

Substance Use & Misuse

2025

Rarely lethal in isolated ingestion, benzodiazepines show an increasing degree of morbidity and mortality associated with overdose when co-ingested with opioids. Several studies have identified a limited number of associated risk and protective factors surrounding concomitant use. Of those studies that used national data, most focused on the consequences of benzodiazepine and opioid co-ingestion rather than risk factors associated with their misuse. Consequently, we aim to elucidate risk factors associated with benzodiazepine and opioid misuse using national data.

View more

Rapid Transition From a Continuous Naloxone Infusion to Sublingual Buprenorphine After an Opioid Overdose: A Case Series

Substance Use & Addiction Journal

2025

With increasing frequency, providers are encountering patients with opioid overdose who recrudesce after intermittent bolus dosing of naloxone. Some patients require a continuous infusion to maintain ventilation, which necessitates admission to a monitored setting. Buprenorphine could shorten the duration of a continuous naloxone infusion (CNI) or preclude the need altogether because its long-lasting partial agonist effects compete with and blunt the respiratory depressant effects of full agonist opioids. This case series describes the replacement by sublingual (SL) buprenorphine of a CNI in patients experiencing prolonged and recurrent respiratory depression from an opioid overdose.

View more

Opioid utilization patterns and predictors for emergency department visits related to ankle sprains between 2016 and 2021: A National Analysis Utilizing Neural Networks

The American Journal of Emergency Medicine

2025

View more

Show All +